Conversely, the expression of APP proteins was up-regulated in the SV2A-silencing virus group compared to the control group (Figure 2B), indicating that SV2A may regulate AD pathogenesis through AD-associated proteins. This evidence concerns the gene SV2A and Alzheimer disease.